Transcriptome Deconvolution of Heterogeneous Tumor Samples with Immune Infiltration.

TitleTranscriptome Deconvolution of Heterogeneous Tumor Samples with Immune Infiltration.
Publication TypeJournal Article
Year of Publication2018
AuthorsWang Z, Cao S, Morris JS, Ahn J, Liu R, Tyekucheva S, Gao F, Li B, Lu W, Tang X, Wistuba II, Bowden M, Mucci L, Loda M, Parmigiani G, Holmes CC, Wang W
JournaliScience
Volume9
Pagination451-460
Date Published2018 Nov 30
ISSN2589-0042
Abstract

Transcriptome deconvolution in cancer and other heterogeneous tissues remains challenging. Available methods lack the ability to estimate both component-specific proportions and expression profiles for individual samples. We present DeMixT, a new tool to deconvolve high-dimensional data from mixtures of more than two components. DeMixT implements an iterated conditional mode algorithm and a novel gene-set-based component merging approach to improve accuracy. In a series of experimental validation studies and application to TCGA data, DeMixT showed high accuracy. Improved deconvolution is an important step toward linking tumor transcriptomic data with clinical outcomes. An R package, scripts, and data are available: https://github.com/wwylab/DeMixTallmaterials.

DOI10.1016/j.isci.2018.10.028
Alternate JournaliScience
PubMed ID30469014
PubMed Central IDPMC6249353
Grant ListP50 CA090381 / CA / NCI NIH HHS / United States
R01 CA183793 / CA / NCI NIH HHS / United States
R01 CA174206 / CA / NCI NIH HHS / United States
P50 CA070907 / CA / NCI NIH HHS / United States
R01 CA158113 / CA / NCI NIH HHS / United States
MC_UP_A390_1107 / MRC_ / Medical Research Council / United Kingdom
Related Faculty: 
Massimo Loda, M.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700